<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38808005</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-561X</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in pain research (Lausanne, Switzerland)</Title><ISOAbbreviation>Front Pain Res (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 headache- NDPH phenotype: a systematic review of case reports.</ArticleTitle><Pagination><StartPage>1376506</StartPage><MedlinePgn>1376506</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1376506</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpain.2024.1376506</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="UNASSIGNED">Post-acute COVID-19 syndrome or "long COVID" affects patients even after the recovery from Covid infection in various ways. Persistent headache or New Daily Persistent Headache (NDPH) is one of such symptoms. In this review, we will discuss about the case-reports of post covid-19 headache- NDPH phenotype both after and in the course of COVID-19 infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Case reports/studies talked about patients having NDPH around the disease either immediately or late post COVID were included. Data was taken from the source and synthesised on a qualitative basis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Literature search showed 3,538 articles, out of which 12 were screened as per the eligibility criteria and finally, 4 case reports on NDPH and Covid-19 were chosen for analysis from the database and by human search. All case reports justify the criteria for acceptability in quality for this systematic review.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">NDPH in and around Covid 19 infection is something that is currently an ingenious debated topic in the scientific community. More case studies should be written and published on the same subject so that a large systematic review could be conducted.</AbstractText><AbstractText Label="TRIAL REGISTRATION INFORMATION" NlmCategory="UNASSIGNED">The review is registered in Prospero with no. <b>Identifier</b> (CRD42022354912).</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">https://www.crd.york.ac.uk/, PROSPERO (CRD42022354912).</AbstractText><CopyrightInformation>&#xa9; 2024 Dhiman, Joshi, Singh, Gyanpuri and Kumar.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dhiman</LastName><ForeName>Neetu Rani</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joshi</LastName><ForeName>Deepika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Royana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyanpuri</LastName><ForeName>Vyom</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Anand</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Banaras Hindu University, Varanasi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pain Res (Lausanne)</MedlineTA><NlmUniqueID>9918227269806676</NlmUniqueID><ISSNLinking>2673-561X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">headache&#x2014;classification</Keyword><Keyword MajorTopicYN="N">pain</Keyword><Keyword MajorTopicYN="N">persistent (chronic) pain</Keyword><Keyword MajorTopicYN="N">review&#x2014;systematic</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>29</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38808005</ArticleId><ArticleId IdType="pmc">PMC11130372</ArticleId><ArticleId IdType="doi">10.3389/fpain.2024.1376506</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martelletti P, Bentivegna E, Luciani M, Spuntarelli V. Headache as a prognostic factor for COVID-19. Time to re-evaluate. SN Compr Clin Med. (2020) 2(12):2509&#x2013;10. 10.1007/s42399-020-00657-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00657-7</ArticleId><ArticleId IdType="pmc">PMC7690334</ArticleId><ArticleId IdType="pubmed">33263101</ArticleId></ArticleIdList></Reference><Reference><Citation>Magdy R, Hussein M, Ragaie C, Abdel-Hamid HM, Khallaf A, Rizk HI, et al. Characteristics of headache attributed to COVID-19 infection and predictors of its frequency and intensity: a cross sectional study. Cephalalgia. (2020) 40(13):1422&#x2013;31. 10.1177/0333102420965140</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965140</ArticleId><ArticleId IdType="pmc">PMC7645600</ArticleId><ArticleId IdType="pubmed">33146038</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard LM, Garguilo K, Gillon J, Seegmiller AC, Schmitz JE, Webber SA, et al. Characteristics and clinical features of SARS-CoV-2 infections among ambulatory and hospitalized children and adolescents in an integrated health care system in Tennessee. medRxiv [Preprint]. (2020). 10.1101/2020.10.08.20208751</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.08.20208751</ArticleId><ArticleId IdType="pmc">PMC7574258</ArticleId><ArticleId IdType="pubmed">33083809</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J Headache Pain. (2010) 11(1):59&#x2013;66. 10.1007/s10194-009-0171-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10194-009-0171-x</ArticleId><ArticleId IdType="pmc">PMC3452180</ArticleId><ArticleId IdType="pubmed">19936615</ArticleId></ArticleIdList></Reference><Reference><Citation>Headache Classification Committee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia. (2004) 24:9&#x2013;160. 10.1111/j.1468-2982.2003.00824.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-2982.2003.00824.x</ArticleId><ArticleId IdType="pubmed">14979299</ArticleId></ArticleIdList></Reference><Reference><Citation>Classification internationale des c&#xe9;phal&#xe9;es (ICHD-3&#x3b2;)11Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Edition-3beta. Cephalalgia. (2013) 33:629&#x2013;809. 10.1177/0333102413485658</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102413485658</ArticleId><ArticleId IdType="pubmed">23771276</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyagi A. New daily persistent headache. Ann Indian Acad Neurol. (2012) 15(Suppl 1):S62&#x2013;5. 10.4103/0972-2327.100011</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-2327.100011</ArticleId><ArticleId IdType="pmc">PMC3444222</ArticleId><ArticleId IdType="pubmed">23024565</ArticleId></ArticleIdList></Reference><Reference><Citation>Uniyal R, Paliwal VK, Tripathi A. Psychiatric comorbidity in new daily persistent headache: a cross-sectional study. Eur J Pain. (2017) 21(6):1031&#x2013;8. 10.1002/ejp.1000</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1000</ArticleId><ArticleId IdType="pubmed">28146324</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo J, Mu&#xf1;oz P, Guitera V, Pascual J. Kaplan award 1998. Epidemiology of chronic daily headache in the general population. Headache. (1999) 39(3):190&#x2013;6. 10.1046/j.1526-4610.1999.3903190.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-4610.1999.3903190.x</ArticleId><ArticleId IdType="pubmed">15613213</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh AK, Shukla R, Trivedi JK, Singh D. Association of psychiatric co-morbidity and efficacy of treatment in chronic daily headache in Indian population. J Neurosci Rural Pract. (2013) 4(2):132&#x2013;9. 10.4103/0976-3147.112736</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0976-3147.112736</ArticleId><ArticleId IdType="pmc">PMC3724287</ArticleId><ArticleId IdType="pubmed">23914085</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron EP, Rothner AD. New daily persistent headache in children and adolescents. Curr Neurol Neurosci Rep. (2010) 10(2):127&#x2013;32. 10.1007/s11910-010-0097-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-010-0097-3</ArticleId><ArticleId IdType="pubmed">20425237</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema S, Mehta D, Ray JC, Hutton EJ, Matharu MS. New daily persistent headache: a systematic review and meta-analysis. Cephalalgia. (2023) 43(5):3331024231168089. 10.1177/03331024231168089</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03331024231168089</ArticleId><ArticleId IdType="pubmed">37032616</ArticleId></ArticleIdList></Reference><Reference><Citation>Arca KN, Starling AJ. Treatment-Refractory Headache in the Setting of COVID-19 Pneumonia: Migraine or Meningoencephalitis?.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314569</ArticleId><ArticleId IdType="pubmed">32838146</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker WJ, Findlay T, Moga C, Scott NA, Harstall C, Taenzer P. Guideline for primary care management of headache in adults. Can Fam Physician. (2015) 61(8):670&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4541429</ArticleId><ArticleId IdType="pubmed">26273080</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. (2015) 4(1):1. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha-Filho S, Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. (2020) 60(8):1797&#x2013;9. 10.1111/head.13941</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13941</ArticleId><ArticleId IdType="pmc">PMC7436496</ArticleId><ArticleId IdType="pubmed">32790179</ArticleId></ArticleIdList></Reference><Reference><Citation>Dono F, Consoli S, Evangelista G, D&#x2019;Apolito M, Russo M, Carrarini C, et al. New daily persistent headache after SARS-CoV-2 infection: a report of two cases. Neurol Sci. (2021) 42(10):3965&#x2013;8. 10.1007/s10072-021-05444-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05444-3</ArticleId><ArticleId IdType="pmc">PMC8280630</ArticleId><ArticleId IdType="pubmed">34264414</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons AC, Bonner A, Giel A, Pezzano A, Rothner AD. Probable new daily persistent headache after COVID-19 in children and adolescents. Pediatr Neurol. (2022) 132:1&#x2013;3. 10.1016/j.pediatrneurol.2022.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9045862</ArticleId><ArticleId IdType="pubmed">35598584</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zkan E, Celebi &#xd6;, Keskin &#xd6;, Gursoy A, G&#xfc;rsoy-&#xd6;zdemir Y. Is persistent post-COVID headache associated with protein-protein interactions between antibodies against viral spike protein and CGRP receptor?: a case report. Front Pain Res (Lausanne). (2022) 3:858709. 10.3389/fpain.2022.858709</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpain.2022.858709</ArticleId><ArticleId IdType="pmc">PMC9011137</ArticleId><ArticleId IdType="pubmed">35434707</ArticleId></ArticleIdList></Reference><Reference><Citation>Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetc R, et al. Chapter 7: systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. Australia: JBI; (2020).</Citation></Reference><Reference><Citation>Rozen TD. New daily persistent headache: an update. Curr Pain Headache Rep. (2014) 18(7):431. 10.1007/s11916-014-0431-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-014-0431-6</ArticleId><ArticleId IdType="pubmed">24820732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamada T, Ohshima K, Ide Y, Sakato S, Takamori M. A case of new daily persistent headache with elevated antibodies to Epstein-Barr virus. Jpn J Med. (1991) 30(2):161&#x2013;3. 10.2169/internalmedicine1962.30.161</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine1962.30.161</ArticleId><ArticleId IdType="pubmed">1650858</ArticleId></ArticleIdList></Reference><Reference><Citation>Riddle EJ, Smith JH. New daily persistent headache: a diagnostic and therapeutic odyssey. Curr Neurol Neurosci Rep. (2019) 19(5):21. 10.1007/s11910-019-0936-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-0936-9</ArticleId><ArticleId IdType="pubmed">30888529</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelletti P, Bentivegna E, Spuntarelli V, Luciani M. Long-COVID headache. SN Compr Clin Med. (2021) 3(8):1704&#x2013;6. 10.1007/s42399-021-00964-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-021-00964-7</ArticleId><ArticleId IdType="pmc">PMC8136258</ArticleId><ArticleId IdType="pubmed">34036244</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiala K, Martens J, Abd-Elsayed A. Post-COVID pain syndromes. Curr Pain Headache Rep. (2022) 26:379&#x2013;83. 10.1007/s11916-022-01038-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01038-6</ArticleId><ArticleId IdType="pmc">PMC8907389</ArticleId><ArticleId IdType="pubmed">35267156</ArticleId></ArticleIdList></Reference><Reference><Citation>Membrilla JA, Caronna E, Trigo-Lopez J. Persistent headache after COVID-19: pathophysiology, clinic and treatment. Neurol Perspect. (2021) 1:S31&#x2013;36. 10.1016/j.neurop.2021.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurop.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8669731</ArticleId><ArticleId IdType="pubmed">38620971</ArticleId></ArticleIdList></Reference><Reference><Citation>Torrente A, Alonge P, Di Stefano V, Baschi R, Ornello R, Correnti E, et al. New-onset headache following COVID-19: an Italian multicentre case series. J Neurol Sci. (2023) 446(120591):120591. 10.1016/j.jns.2023.120591</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2023.120591</ArticleId><ArticleId IdType="pmc">PMC9931424</ArticleId><ArticleId IdType="pubmed">36807975</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha-Filho S, Torres PA, Ramos R. HIV and headache: a cross-sectional study. Headache. (2017) 57:1545&#x2013;50. 10.1111/head.13183</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13183</ArticleId><ArticleId IdType="pubmed">28905376</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack KJ. What incites new daily persistent headache in children? Pediatr Neurol. (2004) 31(2):122&#x2013;5. 10.1016/j.pediatrneurol.2004.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2004.02.006</ArticleId><ArticleId IdType="pubmed">15301832</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozen T, Swidan SZ. Elevation of CSF tumor necrosis factor &#x3b1; levels in new daily persistent headache and treatment refractory chronic migraine. Headache. (2007) 47:1050&#x2013;5. 10.1111/j.1526-4610.2006.00722.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4610.2006.00722.x</ArticleId><ArticleId IdType="pubmed">17635596</ArticleId></ArticleIdList></Reference><Reference><Citation>She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol. (2020) 92(7):747&#x2013;54. 10.1002/jmv.25807</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25807</ArticleId><ArticleId IdType="pmc">PMC7228385</ArticleId><ArticleId IdType="pubmed">32232980</ArticleId></ArticleIdList></Reference><Reference><Citation>Viner RM, Ward JL, Hudson LD, Ashe M, Patel SV, Hargreaves D, et al. Systematic review of reviews of symptoms and signs of COVID-19 in children and adolescents. Arch Dis Child. (2020) 106(8):802&#x2013;7. 10.1136/archdischild-2020-320972</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320972</ArticleId><ArticleId IdType="pubmed">33334728</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: three migraine-like yet distinct scenarios. Headache. (2021) 61(8):1277&#x2013;80. 10.1111/head.14197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J, Radke J, Dittmayer C. Olfactory transmucosal SARS- CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. (2021) 24:168&#x2013;75. 10.1038/s41593-020-00758-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D. From anti-SARS-CoV-2 immune response to the cytokine storm via molecular mimicry. Antibodies (Basel). (2021) 10(4):36. 10.3390/antib10040036</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib10040036</ArticleId><ArticleId IdType="pmc">PMC8544210</ArticleId><ArticleId IdType="pubmed">34698069</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K-P, Wang S-J. Update of new daily persistent headache. Curr Pain Headache Rep. (2022) 26(1):79&#x2013;84. 10.1007/s11916-022-01005-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01005-1</ArticleId><ArticleId IdType="pmc">PMC8787738</ArticleId><ArticleId IdType="pubmed">35076874</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>